1. Home
  2. HRTX vs MRVI Comparison

HRTX vs MRVI Comparison

Compare HRTX & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRTX
  • MRVI
  • Stock Information
  • Founded
  • HRTX 1983
  • MRVI 2014
  • Country
  • HRTX United States
  • MRVI United States
  • Employees
  • HRTX N/A
  • MRVI N/A
  • Industry
  • HRTX Biotechnology: Pharmaceutical Preparations
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • HRTX Health Care
  • MRVI Health Care
  • Exchange
  • HRTX Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • HRTX 325.0M
  • MRVI 312.4M
  • IPO Year
  • HRTX 1987
  • MRVI 2020
  • Fundamental
  • Price
  • HRTX $1.93
  • MRVI $2.24
  • Analyst Decision
  • HRTX Strong Buy
  • MRVI Hold
  • Analyst Count
  • HRTX 2
  • MRVI 10
  • Target Price
  • HRTX $5.50
  • MRVI $6.84
  • AVG Volume (30 Days)
  • HRTX 2.1M
  • MRVI 1.9M
  • Earning Date
  • HRTX 05-06-2025
  • MRVI 05-12-2025
  • Dividend Yield
  • HRTX N/A
  • MRVI N/A
  • EPS Growth
  • HRTX N/A
  • MRVI N/A
  • EPS
  • HRTX N/A
  • MRVI N/A
  • Revenue
  • HRTX $148,518,000.00
  • MRVI $241,856,000.00
  • Revenue This Year
  • HRTX $12.60
  • MRVI N/A
  • Revenue Next Year
  • HRTX $13.66
  • MRVI $11.28
  • P/E Ratio
  • HRTX N/A
  • MRVI N/A
  • Revenue Growth
  • HRTX 12.43
  • MRVI N/A
  • 52 Week Low
  • HRTX $1.04
  • MRVI $1.67
  • 52 Week High
  • HRTX $3.93
  • MRVI $10.03
  • Technical
  • Relative Strength Index (RSI)
  • HRTX 45.93
  • MRVI 52.26
  • Support Level
  • HRTX $1.82
  • MRVI $2.20
  • Resistance Level
  • HRTX $1.93
  • MRVI $2.41
  • Average True Range (ATR)
  • HRTX 0.11
  • MRVI 0.16
  • MACD
  • HRTX -0.00
  • MRVI 0.02
  • Stochastic Oscillator
  • HRTX 56.76
  • MRVI 59.14

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: